The Mumbai-headquartered biopharmaceuticals company was acquired by US-based investor Advent International from its previous owners, the Daftary family, for an undisclosed sum in 2019. Advent, which is now the 100%-owner of BSV, wants to sell the company.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment